作为芳香酶抑制剂的 triazole 类似物的设计和药理学研究
1School of Pharmaceutical Sciences, Guru Ghasidas Central University, Bilaspur, 495009 (C.G.) India.
Anti-cancer agents in medicinal chemistry
|November 3, 2023
概括
研究人员设计了100种新的三醇类似物作为芳香酶抑制剂,用于对抗乳腺癌. 化合物01表现出强烈的活性,显示出开发有毒性降低的向治疗的前景.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 计算化学计算化学
背景情况:
- 乳腺癌仍然是一个重大的全球健康问题.
- 芳香酶抑制剂 (AI) 对于治疗雌激素受体阳性乳腺癌至关重要.
- 现有的人工智能药物存在局限性,需要开发具有改进安全概况的新型向药物.
研究的目的:
- 设计和探索100种新型三醇类似物作为潜在的芳酶抑制剂的药理特征.
- 为了识别具有增强抗乳腺癌活性的强效化合物.
- 为了研究优化AI设计的结构-活动关系.
主要方法:
- 利用分子对接来评估4-替代-1,2,3-triazoles的芳香酶抑制作用.
- 采用自组织分子场分析 (SOMFA) 来评估分子特征和生物活性.
- 使用部分最小平方 (PLS) 和多重线性回归 (MLR) 方法开发了预测模型.
主要成果:
- 确定01化合物是最强大的抑制剂 (IC50 = 0.008μM),超过了莱特.
- 在化合物01和芳香酶残留物Met 374和Arg 115之间建立了关键的键.
- 通过交叉验证的q2 (0.6349) 和非交叉验证的r2 (0.7163) 实现了可靠的预测能力.
- 在100种设计的化合物中,有7种具有显著的芳香酶抑制活性.
结论:
- 开发的SOMFA模型提供了对芳酶-三醇抑制剂相互作用的见解.
- 这些发现支持了未来修改以增强基于三醇的芳酶抑制剂的可能性.
- 这项研究有助于开发针对乳腺癌的向疗法,并有可能减少副作用.
更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.2K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.4K
相关概念视频
Structure-Activity Relationships and Drug Design
734
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
734
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.0K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
3.0K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K
